Invisible Sentinel
bioMérieux is a global leader in in vitro diagnostics, dedicated to improving health and public health through innovative diagnostic solutions. Since 1963, the company has been committed to making the world a healthier place by providing advanced diagnostic tools for infectious diseases, antimicrobial resistance, food safety, pharmaceutical quality control, and respiratory infections, including COVID-19. Their mission is to support healthcare industries and laboratories in making reliable decisions to enhance patient care and safety.
Industries
Nr. of Employees
small (1-50)
Invisible Sentinel
Philadelphia, Pennsylvania, United States, North America
Patents
Methods and compositions for detecting multiple analytes with a single signal
US-10732177-B2
View DetailsAnalyte detection devices, multiplex and tabletop devices for detection of analytes, and uses thereof
US-10705084-B2
View DetailsMethods and compositions for detecting multiple analytes with a single signal
US-10018626-B2
View DetailsMethods and compositions for detecting multiple analytes with a single signal
US-9823240-B2
View Details
Methods and compositions for detecting multiple analytes with a single signal
US-10732177-B2
View DetailsAnalyte detection devices, multiplex and tabletop devices for detection of analytes, and uses thereof
US-10705084-B2
View DetailsMethods and compositions for detecting multiple analytes with a single signal
US-10018626-B2
View DetailsMethods and compositions for detecting multiple analytes with a single signal
US-9823240-B2
View DetailsProducts
Multiplex PCR infectious-disease testing system (rapid panel platform)
A multiplex PCR platform that runs comprehensive infectious-disease panels to detect multiple respiratory or other pathogen targets in a rapid, automated workflow.
MALDI-TOF mass spectrometry system for microbial identification
MALDI-TOF mass spectrometer designed for automated microbial identification workflows in clinical and industrial labs.
Procalcitonin immunoassay for rapid PCT-guided therapy
Immunoassay-based test providing procalcitonin results in ~20 minutes to support antibiotic decision-making.
Automated blood culture microbial detection system with real-time monitoring
Fully automated blood culture solution with real-time notification of sample metrics, fast time to detection, and minimal hands-on time.
Rapid respiratory molecular panel (CLIA-waived format available)
Rapid molecular respiratory testing solution that provides PCR results for common respiratory viruses and bacteria in a short turnaround (minutes), available in CLIA-waived configurations.
Multiplex gastrointestinal pathogen panel
Molecular panel for comprehensive detection of bacterial, viral, and parasitic causes of infectious gastroenteritis from stool specimens.
Multiplex PCR infectious-disease testing system (rapid panel platform)
A multiplex PCR platform that runs comprehensive infectious-disease panels to detect multiple respiratory or other pathogen targets in a rapid, automated workflow.
MALDI-TOF mass spectrometry system for microbial identification
MALDI-TOF mass spectrometer designed for automated microbial identification workflows in clinical and industrial labs.
Procalcitonin immunoassay for rapid PCT-guided therapy
Immunoassay-based test providing procalcitonin results in ~20 minutes to support antibiotic decision-making.
Automated blood culture microbial detection system with real-time monitoring
Fully automated blood culture solution with real-time notification of sample metrics, fast time to detection, and minimal hands-on time.
Rapid respiratory molecular panel (CLIA-waived format available)
Rapid molecular respiratory testing solution that provides PCR results for common respiratory viruses and bacteria in a short turnaround (minutes), available in CLIA-waived configurations.
Multiplex gastrointestinal pathogen panel
Molecular panel for comprehensive detection of bacterial, viral, and parasitic causes of infectious gastroenteritis from stool specimens.
Services
E-commerce service for purchasing diagnostic kits, lab supplies, and consumables with account-based pricing and order management.
Diagnostic solutions and associated guidance to support appropriate antibiotic therapy decisions and stewardship programs.
Integrated diagnostic approaches intended to accelerate sepsis identification and support treatment initiation and monitoring.
E-commerce service for purchasing diagnostic kits, lab supplies, and consumables with account-based pricing and order management.
Diagnostic solutions and associated guidance to support appropriate antibiotic therapy decisions and stewardship programs.
Integrated diagnostic approaches intended to accelerate sepsis identification and support treatment initiation and monitoring.
Expertise Areas
- In vitro diagnostics
- Molecular diagnostics and multiplex PCR
- Clinical microbiology and microbial identification
- Antimicrobial resistance diagnostics and stewardship
Key Technologies
- Multiplex PCR
- Real-time PCR
- MALDI-TOF mass spectrometry
- Automated blood culture detection systems
News & Updates
bioMérieux's BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini received FDA 510(k) clearance and CLIA waiver for the addition of Anterior Nasal Swab as a validated specimen type.
Launch of GENE-UP® PRO HRM, the first DNA-based test to detect heat-resistant molds at the molecular level.
Discussion on new standards recognizing alternative endotoxin testing methods that do not rely on animal-derived products.
bioMérieux reaffirmed its leadership in infectious disease diagnostics and antimicrobial resistance at ADLM 2025.
bioMérieux's BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini received FDA 510(k) clearance and CLIA waiver for the addition of Anterior Nasal Swab as a validated specimen type.
Launch of GENE-UP® PRO HRM, the first DNA-based test to detect heat-resistant molds at the molecular level.
Discussion on new standards recognizing alternative endotoxin testing methods that do not rely on animal-derived products.
bioMérieux reaffirmed its leadership in infectious disease diagnostics and antimicrobial resistance at ADLM 2025.